Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer.
about
Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancerDendritic cell-based cancer immunotherapy for colorectal cancerTargeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
P2860
Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@ast
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@en
Chemoimmunotherapy targeting Wilms' tumor 1
@nl
type
label
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@ast
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@en
Chemoimmunotherapy targeting Wilms' tumor 1
@nl
prefLabel
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@ast
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@en
Chemoimmunotherapy targeting Wilms' tumor 1
@nl
P2093
P2860
P1433
P1476
Chemoimmunotherapy targeting W ...... tients with pancreatic cancer.
@en
P2093
Haruo Sugiyama
Hisao Tajiri
Jianlin Gong
Kazuki Takakura
Masato Okamoto
Sadamu Homma
Shigeo Koido
Toshifumi Ohkusa
P2860
P304
P356
10.4161/21624011.2014.958950
P577
2014-11-01T00:00:00Z